N/A N=177 New Ways to Help Patients Improve Their Diabetes Control
Diabetes Mellitus
Primary: Change in Percent of Glycosylated Hemoglobin 6 Months Following Enrollment — -0.74; -0.55; -0.89 Percent of glycosylated hemoglobin
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=80 Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease
Diabetes · Kidney Diseases
Primary: Mean Glucose Concentration Measured by CGM — 151.5 mg/dL
N/A N=200 Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus
Primary: The Achievement Rate of HbA1c (<7%) — 63; 65; 58; 64 Participants — p=0.9917
N/A N=18 Feasibility of Remote Data Collection With a Point of Care Device to Measure HbA1c
Pregnant · Postpartum
Primary: Feasibility to Obtain HbA1c Through Remote Data Collection — 17; 16 Participants
N/A N=156 Glucose Control Using 1,5-AG Testing
Diabetes
Primary: Diagnosis-Treatment — 31.7; 35.0; 29.1; 31.9 CPV diagnosis-treatment percentage score
Phase 4 N=5 Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients
Hepatitis B
Primary: Differences in Blood Glucose Levels as Measured by GNS-POC, GS-POC and Venous Blood Prior to and After HBIG Injection — -3.2; 6.0; 56.6; -2.6 mg/dL — p=0.59
Phase 4 N=89 Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.
Diabetes · Depression
Primary: HbA1C (%) — 9.7; 10.0; 8.8; 8.0 Percentage of glycosylated hemoglobin
N/A N=89 SMBG Protocols Predicting Glucose Levels in Senior Diabetes Mellitus With CAD
Diabetes Mellitus, Type 2 · Coronary Artery Disease
Primary: Evaluation of Peak and Nadir Glucose Profiles From Continuous Glucose Monitoring System (CGMS) — 8.86; 8.72; 8.80; 6.87 mmol/L
N/A N=150 Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study
Diabetes
Primary: Compare the Pearson Correlation of Glycated Albumin (GA) and Fructosamine Within All Subjects With the Performance Goal of 0.8 — 0.7056; 0.5271 Pearson correlation…
N/A N=170 Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics
Diabetes
Primary: Change From Baseline A1C — 1.1; 1.4 percentage of A1C decrease
N/A N=224 An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes
Type 2 Diabetes Mellitus
Primary: HbA1c at 6 Months — 8.65; 8.75; 8.37; 8.34 percentage of Glycated Haemoglobin — p=0.8222
N/A N=31 Effect of Inpatient Diabetes Management on Outpatient Glycemic Control
Diabetes Mellitus, Type 2
Primary: Hemoglobin A1c — -1.3; -0.4 HbA1c, %
Phase 4 N=117 A Study for Patients With Diabetes Mellitus (IOPA)
Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 2
Primary: Glycosylated Hemoglobin (HbA1c) Value at 12 Week Endpoint — 7.91; 7.96 percent of glycosylated hemoglobin — p=0.497
Phase 2 N=141 Dose-ranging Study in Patients With Type 1 Diabetes Mellitus
Type 1 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1C (A1C) at Week 12 — -0.35; -0.60; -0.84; -0.73 percentage of A1C — p=0.07
N/A N=154 Evaluation of CONTOUR® USB BGMS on Glycaemic Control in Insulin-treated Diabetic Patients
Diabetes Mellitus Type 2
Primary: Reduction in HbA1c — -0.52; -0.14 % (unit of HbA1c)
N/A N=1,409 An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2
Diabetes Mellitus
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) Level at Month 6 — 8.1; -1.2 percentage of glycosylated hemoglobin
N/A N=297 Blood Glucose Testing and You
Diabetes
Primary: Percent of Subjects Outside Specified Blood Glucose (BG) Range -Estimated Versus Measured Blood Glucose — 45.80 percentage of subjects
Phase 4 N=135 A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients
Diabetes Mellitus, Type 2
Primary: Percentage of Participants Achieving Hemoglobin A1c (HbA1c) Below 6.5% at Week 48 Endpoint — 18.5 percentage of participants
Phase 4 N=263 A Study on the Effect of 2 Pen Devices on HbA1c
Diabetes Mellitus, Type 1
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) at Week 24 Endpoint — -0.48; -0.43 percentage of glycosylated hemoglobin — p=0.6692
N/A N=1,939 Opportunistic Screening for Prediabetes and Early Diabetes in Primary Care
Type 2 Diabetes Mellitus · Prediabetic State
Primary: Ability of Different Screening Tests Which Can be Performed Opportunistically (During Outpatient Visits -- at Any Time of Day, Regardless of Meal Status) to Predict…
N/A N=6 Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy
Diabetes Complications · Hypoglycemia
Primary: Percent Enrichment of Bicarbonate as Measured by Magnetic Resonance Spectroscopy (MRS) — 61.9 % enrichment — p=0.0053
N/A N=50 Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation Study
Diabetes Mellitus
Primary: Number of Successful Glucose Readings — 449 Number of Glucose readings in range
Phase 2 N=74 Intensive Glycemic Control for Congestive Heart Failure Exacerbation
Congestive Heart Failure · Diabetes Mellitus
Primary: Hospital Length of Stay — 7; 8 days
N/A N=7,052 Blood Glucose Monitoring in Electronic Health Records
Diabetes Mellitus
Primary: Count of Participants Entering Flowsheet Data During Measurement Period, Extensive Margin — 4; 27; 44; 43 Participants
N/A N=30 Model Driven Diabetes Care
Diabetes Mellitus, Type 1
Primary: Change in the Frequency of Hyper- and Hypo-glycemic Events From Baseline to Week 8-12. — -18; -7.5 Events
N/A N=153 SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c
Diabetes Mellitus, Type 1
Primary: HbA1c at 6 Month — 8.47; 8.04 percentage of glycosylated hemoglobin — p=<0.0001
Phase 4 N=117 Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin
Type-2 Diabetes Mellitus
Primary: Change of Glycosylated Hemoglobin A1c (HbA1c) From Baseline to Month 12 — -0.8; -1.0 percentage of Glycosylated Hemoglobin
N/A N=120 Performance of Contour Next® and Contour Plus Elite® BGMS in Arterial Blood Samples From Hospitalized Adults
Diabetes Mellitus
Primary: Number of Results From the Contour Next BGMSs Reference Values Within ±12.5% of Reference Values — 236 blood samples
Phase 2 N=57 Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes
Diabetes, Gestational
Primary: Correlation Between Glucose AUC and Birth Weight. — 0.2902; 0.2935; 0.2915; 0.2859 correlation coefficient — p=0.035
Phase 2 N=74 Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Congestive Heart Failure · Diabetes Mellitus
Primary: Hospital Length of Stay — 7; 8 days